title: The role of bevacizumab in recurrent glioblastoma: new insights from randomized trials.
authors.affiliation: Medical Oncology Department, Bellaria Maggiore Hospitals, Azienda USL - IRCCS Institute of Neurological Sciences, Bologna, Italy.
authors.forename: Enrico
authors.initials: E
authors.lastname: Franceschi
authors.forename: Alba A
authors.initials: AA
authors.lastname: Brandes
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000628:therapy*; D005260:Female; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D008130:Lomustine
keywords: bevacizumab; glioblastoma; survival